Shockwave Medical Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Shockwave Medical (SWAV) Tops Q2 EPS by 6c, Revenues Beat
August 11, 2020 4:20 PM EDTShockwave Medical (NASDAQ: SWAV) reported Q2 EPS of ($0.56), $0.06 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $10.3 million versus the consensus estimate of $8.35 million.
Recent Highlights
Recognized revenue of $10.3 million for the second quarter of 2020, representing a 3% increase over the second quarter of 2019Completed enrolment in the CAD III pivotal study of IVL for coronary use in the United StatesCompleted... More